Triple

T2371043
Position Surface form Disambiguated ID Type / Status
Subject Rituxan E46089 entity
Predicate oftenUsedWith P4791 FINISHED
Object cyclophosphamide
Cyclophosphamide is a widely used alkylating chemotherapy and immunosuppressive drug commonly employed in the treatment of cancers and autoimmune diseases.
 E261829 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: cyclophosphamide | Statement: [Rituxan, oftenUsedWith, cyclophosphamide]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: cyclophosphamide
Context triple: [Rituxan, oftenUsedWith, cyclophosphamide]
  • A. Alimta
    Alimta is a chemotherapy drug (pemetrexed) primarily used to treat malignant pleural mesothelioma and non-small cell lung cancer.
  • B. Xeloda
    Xeloda is an oral chemotherapy drug (capecitabine) commonly used to treat various cancers, including colorectal and breast cancer.
  • C. bortezomib
    Bortezomib is a proteasome inhibitor chemotherapy drug primarily used in the treatment of multiple myeloma and certain types of lymphoma.
  • D. thalidomide
    Thalidomide is an immunomodulatory drug historically known for causing severe birth defects, now used under strict controls to treat conditions such as multiple myeloma and complications of leprosy.
  • E. methotrexate
    Methotrexate is a disease-modifying antirheumatic drug (DMARD) commonly used to treat autoimmune conditions such as rheumatoid arthritis, psoriasis, and certain cancers by inhibiting folate-dependent cell proliferation.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: cyclophosphamide
Triple: [Rituxan, oftenUsedWith, cyclophosphamide]
Generated description
Cyclophosphamide is a widely used alkylating chemotherapy and immunosuppressive drug commonly employed in the treatment of cancers and autoimmune diseases.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: cyclophosphamide
Target entity description: Cyclophosphamide is a widely used alkylating chemotherapy and immunosuppressive drug commonly employed in the treatment of cancers and autoimmune diseases.
  • A. Alimta
    Alimta is a chemotherapy drug (pemetrexed) primarily used to treat malignant pleural mesothelioma and non-small cell lung cancer.
  • B. Xeloda
    Xeloda is an oral chemotherapy drug (capecitabine) commonly used to treat various cancers, including colorectal and breast cancer.
  • C. bortezomib
    Bortezomib is a proteasome inhibitor chemotherapy drug primarily used in the treatment of multiple myeloma and certain types of lymphoma.
  • D. thalidomide
    Thalidomide is an immunomodulatory drug historically known for causing severe birth defects, now used under strict controls to treat conditions such as multiple myeloma and complications of leprosy.
  • E. methotrexate
    Methotrexate is a disease-modifying antirheumatic drug (DMARD) commonly used to treat autoimmune conditions such as rheumatoid arthritis, psoriasis, and certain cancers by inhibiting folate-dependent cell proliferation.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69a88a145268819083e2736cb835c696 completed March 4, 2026, 7:37 p.m.
NER Named-entity recognition batch_69abc76f5aec8190867d621e6849258c completed March 7, 2026, 6:36 a.m.
NED1 Entity disambiguation (via context triple) batch_69aea8a2b1448190b19179cf379993ee completed March 9, 2026, 11:01 a.m.
NEDg Description generation batch_69aeac6b13ac81909042dddef15ec924 completed March 9, 2026, 11:18 a.m.
NED2 Entity disambiguation (via description) batch_69aead16b0a881909103e26053cfad84 completed March 9, 2026, 11:20 a.m.
Created at: March 4, 2026, 7:56 p.m.